Thoracic injection of low-dose interleukin-2 as an adjuvant therapy improves the control of the malignant pleural effusions: a systematic review and meta-analysis base on Chinese patients

BACKGROUND: Interleukin-2 (IL-2) is an important immunotherapy cytokine for various diseases including cancer. Some studies reported the efficacy and safety on cisplatin combined with IL-2 versus cisplatin alone for treating malignant pleural effusion (MPE) through thoracic injection. METHODS: We se...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Liping, Jiang, Qiufang, Yao, Wei, Fu, Tian, Zeng, Qingdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035446/
https://www.ncbi.nlm.nih.gov/pubmed/29980186
http://dx.doi.org/10.1186/s12885-018-4581-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035446/
https://www.ncbi.nlm.nih.gov/pubmed/29980186
http://dx.doi.org/10.1186/s12885-018-4581-5

Ejemplares similares